Kornelia Schlombs
Mainz, RP 55131, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
Journal: Diagnostic pathology
Published: September 04, 2018
Transferring a Quantitative Molecular Diagnostic Test to Multiple Real-Time Quantitative PCR Platforms.
Journal: The Journal of molecular diagnostics : JMD
Published: October 23, 2017
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Journal: Breast cancer research : BCR
Published: December 05, 2016
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
Journal: Urologia internationalis
Published: August 15, 2016
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
Journal: Virchows Archiv : an international journal of pathology
Published: May 23, 2016
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
Journal: Breast cancer research and treatment
Published: April 08, 2016
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
Journal: BMC cancer
Published: April 08, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026